Xilio Therapeutics (XLO) announced the appointment of Caroline Hensley as chief legal officer. Hensley most recently served as senior vice president, assistant general counsel and chief compliance officer at Seres Therapeutics (MCRB).
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XLO:
- Xilio Therapeutics Reports Q3 2024 Progress and Financials
- Xilio Therapeutics Advances Cancer Drug and Financial Outlook
- Xilio Therapeutics announces initial data from Phase 1C trial for XTX101
- Xilio Therapeutics expects cash to fund operations into Q2 of 2025
- Xilio Therapeutics reports Q3 EPS (22c), consensus (25c)